No abstract available
MeSH terms
-
Blood Glucose / analysis*
-
Diabetes Mellitus, Type 1 / blood
-
Diabetes Mellitus, Type 1 / drug therapy*
-
Drug Monitoring
-
Drug Therapy, Combination / adverse effects
-
Glucagon / administration & dosage*
-
Glucagon / adverse effects
-
Glucagon / therapeutic use
-
Hormone Replacement Therapy* / adverse effects
-
Humans
-
Hyperglycemia / chemically induced
-
Hyperglycemia / prevention & control
-
Hypoglycemia / chemically induced
-
Hypoglycemia / prevention & control
-
Hypoglycemic Agents / administration & dosage
-
Hypoglycemic Agents / adverse effects
-
Hypoglycemic Agents / therapeutic use
-
Infusion Pumps* / adverse effects
-
Insulin / administration & dosage
-
Insulin / adverse effects
-
Insulin / therapeutic use
-
Insulin Infusion Systems* / adverse effects
-
Monitoring, Ambulatory* / adverse effects
-
Randomized Controlled Trials as Topic
Substances
-
Blood Glucose
-
Hypoglycemic Agents
-
Insulin
-
Glucagon